Nitrate-Enriched Beetroot Juice Produces Reduction in Systolic BP in COPD
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 20, 2023 -- For individuals with chronic obstructive pulmonary disease (COPD), dietary nitrate supplementation in the form of beetroot juice results in a sustained reduction in systolic blood pressure (SBP), according to a study published online Dec. 19 in the European Respiratory Journal.
Ali M. Alasmari, from the National Heart and Lung Institute at Imperial College London, and colleagues conducted a randomized trial involving stable COPD patients with home SBP measurement ≥130 mm Hg. Participants were randomly assigned to 70 mL of nitrate-rich beetroot juice (400 mg NO3) or an identical nitrate-depleted placebo juice once daily for 12 weeks (40 and 41 patients, respectively).
The researchers found that active treatment lowered SBP (Hodges-Lemman treatment effect mean difference, −4.5 mm Hg), improved 6-minute walk distance (+30.0 m), and improved measures of endothelial function (reactive hyperemia index [+0.34] and augmentation index [−7.61 percent]) compared with placebo.
"There is some evidence that beetroot juice as a source of nitrate supplementation could be used by athletes to improve their performance, as well as a few short-term studies looking at blood pressure. Higher levels of nitrate in the blood can increase the availability of nitric oxide, a chemical that helps blood vessels relax. It also increases the efficiency of muscles," lead author Nicholas Hopkinson, Ph.D., also of Imperial College London, said in a statement. "This is one of the longest-duration studies in this area so far. The results are very promising, but will need to be confirmed in larger, longer-term studies."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
HTN, Albuminuria Risks No Worse for Kidney Donors Versus Nondonors
THURSDAY, May 30, 2024 -- Living kidney donors and nondonors have similar risks for hypertension and albuminuria, according to a study published online May 23 in the Journal of...
Antihypertensives Linked to Eczematous Dermatitis in Seniors
FRIDAY, May 24, 2024 -- Antihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and...
Researchers Compare Race-Based, Race-Neutral Lung Function Equations
TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.